PH
Promod Haque
10% Owner

Promod Haque insider trades: Impel Neuropharma (IMPL) stock buys and sales

10% Owner, Impel Neuropharma Last trade Apr 27, 2021 102 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
55
Open-market trades
since 2005
21
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Promod reports to the SEC

and 15 more companies

Open-market buys and sales

55 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 27, 2021IMPL↑ Buy$12.4M
Nov 10, 2016APIC↓ Sell$5.2M
Mar 12, 2014FEYE↓ Sell$159.7M
Dec 17, 2013SALE↓ Sell$26.0M
Jul 24, 2013SALE↓ Sell$33.0M
Nov 16, 2009RAX↓ Sell$1.7M
Mar 13, 2009RAX↑ Buy$1.2M
Mar 11, 2009RAX↑ Buy$573K
Mar 5, 2009RAX↑ Buy$214K
Mar 4, 2009RAX↑ Buy$77K
Mar 3, 2009RAX↑ Buy$578K
Feb 27, 2009RAX↑ Buy$913K
Feb 25, 2009RAX↑ Buy$1.5M
Feb 25, 2009RAX↑ Buy$7K
Feb 24, 2009RAX↑ Buy$964K
Feb 24, 2009RAX↑ Buy$340K
Nov 26, 2008RAX↑ Buy$29K
Nov 25, 2008RAX↑ Buy$357K
Nov 25, 2008RAX↑ Buy$242K
Nov 25, 2008RAX↑ Buy$85K
Nov 24, 2008RAX↑ Buy$154K
Nov 24, 2008RAX↑ Buy$595
Nov 20, 2008RAX↑ Buy$2.6M
Nov 20, 2008RAX↑ Buy$1.0M
Nov 19, 2008RAX↑ Buy$653K
Nov 17, 2008RAX↑ Buy$10K
Nov 14, 2008RAX↑ Buy$329K
Nov 14, 2008RAX↑ Buy$6K
Nov 12, 2008RAX↑ Buy$201K
Nov 11, 2008RAX↑ Buy$1.5M
Nov 11, 2008RAX↑ Buy$318K
Nov 11, 2008RAX↑ Buy$25K
Nov 10, 2008RAX↑ Buy$181K
Nov 10, 2008RAX↑ Buy$118K
Nov 10, 2008RAX↑ Buy$10K
Aug 29, 2008VRAZ↑ Buy$50K
Aug 27, 2008VRAZ↑ Buy$4K
Aug 26, 2008VRAZ↑ Buy$162K
Aug 22, 2008VRAZ↑ Buy$435K
Aug 20, 2008VRAZ↑ Buy$428K
Aug 18, 2008VRAZ↑ Buy$12K
Aug 15, 2008VRAZ↑ Buy$41K
Aug 14, 2008VRAZ↑ Buy$42K
Aug 13, 2008VRAZ↑ Buy$28K
Aug 13, 2008RAX↑ Buy$10.8M
Nov 14, 2006OCNW↓ Sell$1.6M
Nov 14, 2006OCNW↓ Sell$81K
Nov 7, 2006OCCM.OB↓ Sell$4.0M
Nov 7, 2006OCCM.OB↓ Sell$202K
May 12, 2006WSPI↓ Sell$173K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Promod Haque's insider trades

Promod Haque is a 10% owner of Impel Neuropharma (IMPL). Since Nov 22, 2005, Promod has reported 40 open-market purchases worth $38.6M and 15 sales worth $232.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (29 filings), conversions (14 filings), grants and awards (11 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMPL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.